Nuo Therapeutics, Inc.

Medical device company · Houston, Texas, United States · OTC: AURX

Nuo Therapeutics, Inc. is a medical device company headquartered in Houston, Texas, United States. Its shares trade on OTC under the ticker AURX. The US FDA lists 1 medical device site registered to the company, with devices in cardiovascular and clinical chemistry. It has reported private securities offerings to the US SEC, most recently $791,418 sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Nuo Therapeutics at a glance

Typemedical device company
HeadquartersHouston, Texas, United States
Stock listingOTC: AURX
SEC industrySurgical & Medical Instruments & Apparatus
FDA-registered sites1
SEC CIK1091596

What does Nuo Therapeutics do?

Medical specialties of its FDA-listed devices

CardiovascularClinical Chemistry

Device types listed with the FDA

Phlebotomy blood collection kitCentrifuges (micro, ultra, refrigerated) for clinical use

Private fundraising reported to the SEC

16 Form D notices; the most recent reported $791,418 sold (2025).

Where is Nuo Therapeutics located?

Headquarters: Houston, Texas, United States

  • Houston, TexasNuo Therapeutics, Inc. · FDA device site

Frequently asked questions about Nuo Therapeutics

Where is Nuo Therapeutics headquartered?

Nuo Therapeutics, Inc. is headquartered in Houston, Texas, United States.

What does Nuo Therapeutics do?

Nuo Therapeutics, Inc. is a medical device company. Its FDA-listed medical devices fall under cardiovascular and clinical chemistry. Its SEC industry classification is Surgical & Medical Instruments & Apparatus.

Is Nuo Therapeutics a public company?

Yes. Nuo Therapeutics, Inc. trades on OTC under the ticker AURX.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.